Mr. Schweitzer has 28 years of experience in the medical device industry. Biomodex hopes his skills will drive its neurovascular and cardiac portfolios toward commercialization.
During his 10-year tenure at Medtronic, he held several executive leadership roles, including vice president of the company’s neuro and cardiac business units, where he oversaw the $2 billion neuromodulation division.
Before joining Medtronic, Mr. Schweitzer served as vice president of medical device manufacturer Boston Scientific.
He is also CEO and cofounder of Neuromodtronic GmbH, a developer of noninvasive optic nerve stimulation for the treatment of neurological disorders.
More articles on devices:
How Dr. Vladimir Sinkov opened his solo spine practice in the midst of the COVID-19 pandemic
Steadman Clinic moves to absorb hospital orthopedic group — 6 things to know
Michigan group to open 7th location, add 2 orthopedic surgeons
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.